Pulmonx (LUNG) EBT Margin Growth (1y) (2020 - 2025)
Pulmonx (LUNG) EBT Margin Growth (1y) (2020 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | -419.00 |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 110.00 |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 458.00 |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 507.00 |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -287.00 |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 772.00 |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 233.00 |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -464.00 |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Pulmonx | 49.94 Mn | -19.81 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 412.00 |
| Jun 30, 2025 | 1,049.00 |
| Mar 31, 2025 | 843.00 |
| Dec 31, 2024 | 1,548.00 |
| Sep 30, 2024 | 1,556.00 |
| Jun 30, 2024 | 2,004.00 |
| Mar 31, 2024 | 3,633.00 |
| Dec 31, 2023 | 2,025.00 |
| Sep 30, 2023 | 2,096.00 |
| Jun 30, 2023 | 1,128.00 |
| Mar 31, 2023 | 3,788.00 |
| Dec 31, 2022 | 277.00 |
| Sep 30, 2022 | -2,852.00 |
| Jun 30, 2022 | 90.00 |
| Mar 31, 2022 | -1,151.00 |
| Dec 31, 2021 | 59.00 |
| Sep 30, 2021 | -4,053.00 |
| Jun 30, 2021 | 21,720.00 |
| Mar 31, 2021 | -5,252.00 |
| Dec 31, 2020 | -5,066.00 |